{
    "clinical_study": {
        "@rank": "109140", 
        "arm_group": [
            {
                "arm_group_label": "Saline", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Assessment   of experimental pain models before and after treatment"
            }, 
            {
                "arm_group_label": "Apomorphine", 
                "arm_group_type": "Active Comparator", 
                "description": "Assessment   of experimental pain models before and after treatment"
            }
        ], 
        "brief_summary": {
            "textblock": "The aims of this study were to assess the effects of the dopamine agonist apomorphine on\n      experimental pain models in healthy subjects and to explore the possible association between\n      these effects and a common polymorphism within the dopamine transporter gene."
        }, 
        "brief_title": "Apomorphine Effects on Experimental Pain", 
        "completion_date": {
            "#text": "July 2011", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "detailed_description": {
            "textblock": "Healthy volunteers (n=105) participated in this randomized double-blind, placebo-controlled,\n      cross-over trial. Heat pain threshold and intensity, cold pain threshold, and the response\n      to tonic cold pain (latency, intensity, and tolerance) were evaluated before and for up to\n      120 min after the administration of 1.5 mg apomorphine/placebo. A polymorphism (DAT-1)\n      within the dopamine transporter gene (SLC6A3) was investigated."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - healthy and free from chronic pain of any type did not use any medications other than\n        oral contraceptives were able to understand the purpose and instructions of the study.\n\n        Exclusion Criteria:\n\n        - any type of medical or painful condition use of medications or recreational drugs\n        pregnancy."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "105", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 6, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01744964", 
            "org_study_id": "0078-09-RBM"
        }, 
        "intervention": {
            "arm_group_label": "Apomorphine", 
            "description": "1.5 mg apomorphine", 
            "intervention_name": "Apomorphine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Apomorphine", 
                "Dopamine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "apomorphine", 
            "dopamine transporter gene", 
            "SLC6A3", 
            "cold pressor test", 
            "tolerance", 
            "experimental pain", 
            "dopamine agonist"
        ], 
        "lastchanged_date": "December 6, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Haifa", 
                    "country": "Israel"
                }, 
                "name": "Rambam Health Care Campus"
            }
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "Alterations in the Ability to Tolerate Experimental Pain by Apomorphine and Its Association With a Dopamine Transporter Polymorphism", 
        "overall_official": {
            "affiliation": "Rambam Health Care Campus, Haifa, Israel", 
            "last_name": "Elon Eisenberg, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Israel: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "July 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Cold pain tolerance", 
            "safety_issue": "No", 
            "time_frame": "120 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01744964"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Rambam Health Care Campus", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rambam Health Care Campus", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}